Trylon Corporation, The – Trademark Portfolio

Entity Type: 03

Trylon Corporation, The holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SPIRABRUSH CX. The owner is based in Torrance, CA.

970 West 190th Street

Suite 220

Torrance, CA 90502

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Trylon Corporation, The's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (7 filings)

Surgical, medical, dental and veterinary apparatus and instruments

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Trylon Corporation, The have?

Trylon Corporation, The has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 3 cancelled.

What trademark classes does Trylon Corporation, The file in?

Trylon Corporation, The files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Trylon Corporation, The's most well-known trademarks?

Trylon Corporation, The's registered trademark portfolio includes well-known marks such as SPIRABRUSH CX. These are among 1 currently registered trademark in the portfolio.

What is Trylon Corporation, The's trademark registration success rate?

Trylon Corporation, The has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.